• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The year in cardiovascular medicine 2020: epidemiology and prevention.

作者信息

Estruch Ramon, Ruilope Luis M, Cosentino Francesco

机构信息

Department of Internal Medicine, Hospital Clínic, IDIBAPS, University of Barcelona, Villarroel, 170. 08036 Barcelona, Spain.

CIBER Fisiopatología de la Obesidad y la Nutrición, CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain.

出版信息

Eur Heart J. 2021 Feb 21;42(8):813-821. doi: 10.1093/eurheartj/ehaa1062.

DOI:10.1093/eurheartj/ehaa1062
PMID:33388753
Abstract
摘要

相似文献

1
The year in cardiovascular medicine 2020: epidemiology and prevention.2020年心血管医学领域：流行病学与预防
Eur Heart J. 2021 Feb 21;42(8):813-821. doi: 10.1093/eurheartj/ehaa1062.
2
Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention.预防是幻想，还是医学的未来？心血管疾病预防的近期数据、现状及方向全景概览。
Ther Adv Cardiovasc Dis. 2011 Feb;5(1):61-81. doi: 10.1177/1753944710391350. Epub 2010 Dec 23.
3
Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment.肥胖与心血管风险：欧洲高血压学会肥胖、糖尿病和高危患者工作组及欧洲肥胖研究协会的行动呼吁：A 部分：肥胖引起的高血压、糖尿病和血脂异常的机制以及治疗实践指南。
J Hypertens. 2018 Jul;36(7):1427-1440. doi: 10.1097/HJH.0000000000001730.
4
[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].[心血管风险与心脏代谢风险：一项流行病学评估]
G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S.
5
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.女性心血管疾病预防的循证指南。美国心脏协会科学声明。
Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):e29-50. doi: 10.1161/01.ATV.0000114834.85476.81.
6
Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.应对美国东南部高血压、血脂异常、糖尿病和代谢综合征的全球心血管风险，第二部分：高血压、血脂异常、糖尿病和代谢综合征全球心血管风险管理的治疗建议
Am J Med Sci. 2005 Jun;329(6):292-305. doi: 10.1097/00000441-200506000-00009.
7
[Chronic kidney disease-a cardiovascular high-risk constellation].[慢性肾脏病——心血管高危综合征]
Internist (Berl). 2020 Apr;61(4):340-348. doi: 10.1007/s00108-019-00686-y.
8
[Epidemiology and prevention of cardiovascular diseases].[心血管疾病的流行病学与预防]
Orv Hetil. 2005 Apr 10;146(15):683-8.
9
Strategies for prevention of adult hypertension and cardiovascular risk behaviour in childhood. An Australian perspective.儿童期预防成人高血压和心血管风险行为的策略。澳大利亚视角。
J Hum Hypertens. 1996 Feb;10 Suppl 1:S51-4.
10
Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study.在阿卜杜勒阿齐兹国王大学医院的普通诊所就诊的高危人群中的心血管危险因素：一项横断面研究。
BMC Cardiovasc Disord. 2019 Nov 27;19(1):268. doi: 10.1186/s12872-019-1261-6.

引用本文的文献

1
Harnessing the power of structure-based design: A new lease on life for cardiovascular drug development with apelin receptor modulators.利用基于结构的设计力量：阿片肽受体调节剂为心血管药物开发带来新的生机。
Clin Transl Med. 2024 Dec;14(12):e70116. doi: 10.1002/ctm2.70116.
2
Individually Perceived Parameters of Residential Infrastructure and Their Relationship with Cardiovascular Risk Factors.居住基础设施的个体感知参数及其与心血管危险因素的关系。
Healthcare (Basel). 2024 Oct 7;12(19):2004. doi: 10.3390/healthcare12192004.
3
Cardiovascular prevention in elderly patients.
老年患者的心血管疾病预防
J Geriatr Cardiol. 2022 May 28;19(5):377-392. doi: 10.11909/j.issn.1671-5411.2022.05.004.
4
Importance of ideal cardiovascular health metrics in the risk of colorectal cancer among people aged 50 years or older: a UK Biobank cohort study.50 岁及以上人群中心血管健康理想指标对结直肠癌风险的影响：一项英国生物库队列研究。
BMJ Open. 2022 May 24;12(5):e059642. doi: 10.1136/bmjopen-2021-059642.
5
Repurposing drugs to treat cardiovascular disease in the era of precision medicine.精准医学时代的药物再利用：治疗心血管疾病。
Nat Rev Cardiol. 2022 Nov;19(11):751-764. doi: 10.1038/s41569-022-00717-6. Epub 2022 May 23.
6
Bellidifolin Inhibits SRY-Related High Mobility Group-Box Gene 9 to Block TGF- Signalling Activation to Ameliorate Myocardial Fibrosis.雏菊叶龙胆苷通过抑制SRY相关高迁移率族盒基因9来阻断转化生长因子信号激活，从而改善心肌纤维化。
Evid Based Complement Alternat Med. 2022 May 9;2022:6841276. doi: 10.1155/2022/6841276. eCollection 2022.
7
Cardiogenic shock caused by Takotsubo syndrome complicated with severe anxiety: A case report and literature review.因 Takotsubo 综合征并发严重焦虑导致的心源性休克：病例报告及文献复习。
Medicine (Baltimore). 2021 Nov 12;100(45):e27812. doi: 10.1097/MD.0000000000027812.
8
The Johns Hopkins Ciccarone Center's expanded 'ABC's approach to highlight 2020 updates in cardiovascular disease prevention.约翰·霍普金斯西卡罗内中心扩展了“ABC方法”，以突出2020年心血管疾病预防方面的更新内容。
Am J Prev Cardiol. 2021 Apr 5;6:100181. doi: 10.1016/j.ajpc.2021.100181. eCollection 2021 Jun.